Recently, PAI-1 has also been identified as a regulator of programmed death-ligand 1 (PD-L1) expression, and its adjuvant inhibition may improve anti-PD-L1 therapy in melanoma [59, 60]. This evidence concerns the gene SERPINE1 and melanoma.